These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3523547)

  • 1. [Thrombocyte aggregation inhibitors--a new class of active substances. 2. Chemical and pharmacologic aspects of some agents].
    Böhm R
    Pharmazie; 1986 Feb; 41(2):81-7. PubMed ID: 3523547
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibition of platelet aggregation by platelet inhibitory agents and its relation to their clinical effects].
    Yasunaga K
    Rinsho Byori; 1979; Suppl 40():181-7. PubMed ID: 551223
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibitors of immune complex induced human platelet aggregation and release in plasma.
    Clark WF; Tevaarwerk GJ; Moriarity TA; Reid BD
    Thromb Res; 1982 Dec; 28(5):681-8. PubMed ID: 7167877
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspirin and other platelet-aggregation inhibiting drugs.
    Gallus AS
    Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Present situation of therapy with platelet aggregation inhibitors].
    Poliwoda H
    Acta Med Austriaca Suppl; 1982; 25():55-61. PubMed ID: 6958157
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiplatelet therapy.
    Sloan RW
    Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on vasoactive heterocyclic compounds. Preparation and evaluation of the hypotensive and antiaggregating activities of phthalazinol nitrates.
    Ito S; Komoda Y; Sekizaki S; Azuma H; Ishikawa M
    Chem Pharm Bull (Tokyo); 1988 Jul; 36(7):2669-72. PubMed ID: 3240486
    [No Abstract]   [Full Text] [Related]  

  • 8. Modulation of the inhibitory action of prostaglandin E1 on platelet aggregation in rats: a study with ticlopidine, aspirin, dipyridamole and sulfinpyrazone.
    Tuong CC; Ferrand C; Aubert D; Loubrie JC; Tuong A
    Biochem Pharmacol; 1982 Mar; 31(6):1147-50. PubMed ID: 7200772
    [No Abstract]   [Full Text] [Related]  

  • 9. [Indications and uncertainties of antiaggregating agents].
    Verstraete M
    Rev Prat; 1977 Dec; 27(57):3999-4005. PubMed ID: 345400
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anti-platelet aggregation effect of PGI2 potentiated by EG-626].
    Tanaka K; Harada Y; Katori M
    Rinsho Byori; 1979; Suppl 40():188-91. PubMed ID: 399308
    [No Abstract]   [Full Text] [Related]  

  • 11. Some pyrrolidine and pyrrolizine derivatives as inhibitors of blood platelet aggregation.
    Makoni SH; Sugden JK
    Arzneimittelforschung; 1980; 30(7):1135-7. PubMed ID: 7191295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syntheses and biological properties of 8-carbamoylimidazo[1,2-c]pyrimidines and their heterocyclic analogs.
    Długosz A
    Pharmazie; 1987 Jun; 42(6):381-3. PubMed ID: 3499618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacology of aggregation inhibitors].
    Weber E
    Med Welt; 1976 Jun; 27(25):1217-21. PubMed ID: 933806
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological properties of drug inhibiting platelet aggregation.
    de Gaetano G
    Acta Clin Belg; 1975; 30(3):184-9. PubMed ID: 1231456
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevention of cardiovascular diseases by inhibitors of platelet aggregation (author's transl)].
    Boeynaems JM
    Rev Med Brux; 1982 Jun; 3(6):415-24. PubMed ID: 7111939
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antiaggregants of thrombocytes in ischemic heart disease].
    Beloev I ; Tomov I; TŭrnovskaR
    Vutr Boles; 1985; 24(5):1-6. PubMed ID: 2868572
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mode of action and clinical evaluation of platelet aggregation inhibitors].
    David JL
    Rev Med Liege; 1987 May; 42(10):526-33. PubMed ID: 3616303
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of Anturane and aspirin on thrombocyte aggregation].
    Ciko Z; Stanimirović D
    Vojnosanit Pregl; 1984; 41(5):341-5. PubMed ID: 6516242
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical pharmacology of anti-aggregating substances.
    Vermylen J
    Acta Clin Belg; 1975; 30(3):204-9. PubMed ID: 1231459
    [No Abstract]   [Full Text] [Related]  

  • 20. [Relationship between inhibitory effect of anti-platelet drugs on platelet aggregation and clinical value (author's transl)].
    Yasunaga K; Kanzaki M
    Nihon Ketsueki Gakkai Zasshi; 1979 Jun; 42(3):552-3. PubMed ID: 495017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.